BNP Paribas Financial Markets
AUTL

BNP Paribas Financial Markets’s Autolus Therapeutics AUTL Stock Holding History

BNP Paribas Financial Markets’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
6,882
+2,300
+50% +$3.61K ﹤0.01% 5367
2026
Q1 		$6.32K Sell
4,582
-200
-4% -$304 ﹤0.01% 5291
2025
Q4 		$9.52K Buy
4,782
+2,106
+79% +$3.24K ﹤0.01% 5170
2025
Q3 		$4.36K Sell
2,676
-46
-2% -$90 ﹤0.01% 5105
2025
Q2 		$6.21K Sell
2,722
-30,937
-92% -$51.2K ﹤0.01% 4934
2025
Q1 		$52.2K Buy
33,659
+1,197
+4% +$2.43K ﹤0.01% 4278
2024
Q4 		$76.3K Sell
32,462
-34,661
-52% -$117K ﹤0.01% 4265
2024
Q3 		$244K Sell
67,123
-43,254
-39% -$172K ﹤0.01% 3180
2024
Q2 		$384K Sell
110,377
-5,022
-4% -$21.7K ﹤0.01% 2797
2024
Q1 		$736K Buy
115,399
+111,131
+2,604% +$693K ﹤0.01% 2649
2023
Q4 		$27.5K Buy
4,268
+3,292
+337% +$12.6K ﹤0.01% 3642
2023
Q3 		$2.27K Buy
+976
New +$2.78K ﹤0.01% 3709
2023
Q1 		– Sell
-293
Closed -$557 – 3862
2022
Q4 		$557 Buy
293
+227
+344% +$574 ﹤0.01% 3851
2022
Q3 		$141 Sell
66
-944
-93% -$2.8K ﹤0.01% 4631
2022
Q2 		$2.86K Buy
+1,010
New +$3.07K ﹤0.01% 3854
2021
Q3 		– Sell
-35
Closed -$232 – 4013
2021
Q2 		$232 Buy
+35
New +$217 ﹤0.01% 3998

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BNP Paribas Financial Markets's AUTL Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Autolus Therapeutics (AUTL) stake by 50% in Q2 2026, buying an estimated $3.61K and bringing the position to 6,882 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #5367.

BNP Paribas Financial Markets first reported a position in AUTL in Q2 2021 and has held it in 16 quarters since. The position peaked at $736K in Q1 2024. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • BNP Paribas Financial Markets held 6,882 shares of Autolus Therapeutics worth $11K as of Q2 2026.
  • BNP Paribas Financial Markets bought 2,300 Autolus Therapeutics shares in Q2 2026, an estimated $3.61K.
  • Autolus Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5367 holding.
  • BNP Paribas Financial Markets first reported a position in Autolus Therapeutics in Q2 2021 and has held it in 16 quarters since.
  • BNP Paribas Financial Markets's Autolus Therapeutics position peaked at $736K in Q1 2024.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.